Organisers: Vishu Kumar Aimanianda (Dpt Mycology) Carmen Buchrieser (Dpt Microbiology) Thierry Fontaine (Dpt Mycology) Ivo Gomperts Boneca (Dpt Microbiology)
A groundbreaking set of studies Science (Bastard et al., 2020; Zhang et al., 2020) lead by the Covid Human Genetic effort, has shown that more than 10% of the 987 patients with life-threatening COVID-19 […]
Dans le cadre de l’étude SEROCoV-HUS, pilotée par le Pr Samira Fafi-Kremer (HUS – Université de Strasbourg – INSERM UMR1109), l’équipe du CHRU de Strasbourg, en collaboration avec l’Institut Pasteur, a suivi pendant un an 1309 […]
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Aurélien Corneau, Jeremy Boussier, Nikaïa Smith, Hélène Péré, Bruno Charbit, Vincent Bondet, Camille Chenevier-Gobeaux, Paul Breillat, […]
In this study published in J. Clinic. Microbiol. this month, Sarah Dellière and colleagues from the Alanio’s group at the Molecular Mycology team assess 7 mycological criteria with the aim of improving the diagnosis […]
Tracking the neural stem cell subtypes in vivo We combined intravital imaging, genetic tracing in vivo and biophysical modeling in the adult zebrafish to quantitatively characterize brain neural stem cell dynamics during adult life. […]
Quel est l’objectif de cette étude? Cette étude a pour objectif d’étudier et de suivre au cours du temps la réponse du système immunitaire induite par la vaccination contre la COVID-19, selon différents schémas […]
This mandatory training program, required for all Institut Pasteur PhD students, begins with a group of common core courses including a knowledge base in reproducible research, R Programming and Statistics. Each student then can […]
Since the start of the COVID-19 pandemic, various therapeutic approaches have been explored to tackle the disease. Scientists from the Institut Pasteur have shown that ivermectin, a drug used commercially as an antiparasitic treatment, […]
Since the start of the COVID-19 pandemic, various therapeutic approaches have been explored to tackle the disease. Scientists from the Institut Pasteur have shown that ivermectin, a drug used commercially as an antiparasitic treatment, […]
On April 7, 2021, the European Medical Agency (EMA) concluded that thrombosis in combination with thrombocytopenia has been identified as a likely adverse event following vaccination with the COVID-19 vaccine Vaxzevria. Researchers from the Mathematical Modelling […]
An analysis of the COVID-19 infodemic, and specifically on its impact on offline behavior by Tamara Giles-Vernick Communication during the online conference : The COVID-19 Outbreak and Public Health Issues: an Interdisciplinary Approach. Institut […]
In the framework of its partnership with the Emulate company, the Biomaterials and Microfluidics platform of the DTPS is announcing, along with the DARRI and Carnot Pasteur MS Institute, its second internal call for […]
The EMBO Workshop on Tuberculosis 2022, originally planned for September 2020 and postponed to 2022 due to the Covid-19 pandemic, has recently received again the support from EMBO, and is now scheduled to be […]
Quel est le but de cette étude ? L’objectif est d’étudier la réponse immunitaire contre le SARS-CoV-2 chez des personnes ayant présenté deux épisodes distincts de la Covid-19. Qui peut participer ? Toute personne […]
